MelaFind® technology
for the non-invasive analysis of irregular moles. MelaFind uses 10 different wavelengths of light to examine a mole deep in the skin. It can obtain data from a mole as deep as 2.5 mm. The MelaFind system then utilizes advanced computer programs to analyze the features of a mole. In less than 60 seconds, we can determine if the mole has irregular growth patterns underneath the skin. This gives us additional information when deciding whether to biopsy an irregular mole. MelaFind was shown to detect melanoma at a rate of 98% resulting in fewer unnecessary biopsies of benign moles.
MelaFind is a trademark of MELA SCIENCES, INC

Photodynamic Therapy or Blu-U
a new treatment of actinic keratosis, the pre-cancerous lesions caused by excessive sun exposure. Actinic keratoses are considered to be the first step in the development of the type of skin cancer called squamous cell carcinoma. Approximately 10% of actinic keratoses can develop into squamous cell carcinoma. Left untreated, squamous cell carcinoma can metastasize and result in death.

Photodynamic therapy represents a significant therapeutic advance for patients with actinic keratosis. It is a extremely effective treatment that has high ratings for a cosmetic response. No scarring has been reported to date.

It is a convenient, in-office procedure that requires no anesthetic. A topical solution is applied to the skin. Pre-cancerous cells will absorb the medication and convert it to a form that is very sensitive to light. When the cells are exposed to the blue light illuminator in the office, a reaction occurs destroying the pre-cancerous cells.